Trump’s generic drug tariff bomb: Why it’s not good news for India’s pharma giants
The move is aimed at encouraging pharmaceutical companies to move production to the United States. India, which supplies a large share of generic medicines consumed in America, is expected to be among the countries most affected by the policy.
Top Stories India 
The move is aimed at encouraging pharmaceutical companies to move production to the United States. India, which supplies a large share of generic medicines consumed in America, is expected to be among the countries most affected by the policy.
